Cargando…

Atopic Dermatitis: The Fate of the Fat

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease in which dry and itchy skin may develop into skin lesions. AD has a strong genetic component, as children from parents with AD have a two-fold increased chance of developing the disease. Genetic risk loci and epigenetic modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavel, Petra, Blunder, Stefan, Moosbrugger-Martinz, Verena, Elias, Peter M., Dubrac, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880331/
https://www.ncbi.nlm.nih.gov/pubmed/35216234
http://dx.doi.org/10.3390/ijms23042121
_version_ 1784659168143081472
author Pavel, Petra
Blunder, Stefan
Moosbrugger-Martinz, Verena
Elias, Peter M.
Dubrac, Sandrine
author_facet Pavel, Petra
Blunder, Stefan
Moosbrugger-Martinz, Verena
Elias, Peter M.
Dubrac, Sandrine
author_sort Pavel, Petra
collection PubMed
description Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease in which dry and itchy skin may develop into skin lesions. AD has a strong genetic component, as children from parents with AD have a two-fold increased chance of developing the disease. Genetic risk loci and epigenetic modifications reported in AD mainly locate to genes involved in the immune response and epidermal barrier function. However, AD pathogenesis cannot be fully explained by (epi)genetic factors since environmental triggers such as stress, pollution, microbiota, climate, and allergens also play a crucial role. Alterations of the epidermal barrier in AD, observed at all stages of the disease and which precede the development of overt skin inflammation, manifest as: dry skin; epidermal ultrastructural abnormalities, notably anomalies of the lamellar body cargo system; and abnormal epidermal lipid composition, including shorter fatty acid moieties in several lipid classes, such as ceramides and free fatty acids. Thus, a compelling question is whether AD is primarily a lipid disorder evolving into a chronic inflammatory disease due to genetic susceptibility loci in immunogenic genes. In this review, we focus on lipid abnormalities observed in the epidermis and blood of AD patients and evaluate their primary role in eliciting an inflammatory response.
format Online
Article
Text
id pubmed-8880331
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88803312022-02-26 Atopic Dermatitis: The Fate of the Fat Pavel, Petra Blunder, Stefan Moosbrugger-Martinz, Verena Elias, Peter M. Dubrac, Sandrine Int J Mol Sci Review Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease in which dry and itchy skin may develop into skin lesions. AD has a strong genetic component, as children from parents with AD have a two-fold increased chance of developing the disease. Genetic risk loci and epigenetic modifications reported in AD mainly locate to genes involved in the immune response and epidermal barrier function. However, AD pathogenesis cannot be fully explained by (epi)genetic factors since environmental triggers such as stress, pollution, microbiota, climate, and allergens also play a crucial role. Alterations of the epidermal barrier in AD, observed at all stages of the disease and which precede the development of overt skin inflammation, manifest as: dry skin; epidermal ultrastructural abnormalities, notably anomalies of the lamellar body cargo system; and abnormal epidermal lipid composition, including shorter fatty acid moieties in several lipid classes, such as ceramides and free fatty acids. Thus, a compelling question is whether AD is primarily a lipid disorder evolving into a chronic inflammatory disease due to genetic susceptibility loci in immunogenic genes. In this review, we focus on lipid abnormalities observed in the epidermis and blood of AD patients and evaluate their primary role in eliciting an inflammatory response. MDPI 2022-02-14 /pmc/articles/PMC8880331/ /pubmed/35216234 http://dx.doi.org/10.3390/ijms23042121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pavel, Petra
Blunder, Stefan
Moosbrugger-Martinz, Verena
Elias, Peter M.
Dubrac, Sandrine
Atopic Dermatitis: The Fate of the Fat
title Atopic Dermatitis: The Fate of the Fat
title_full Atopic Dermatitis: The Fate of the Fat
title_fullStr Atopic Dermatitis: The Fate of the Fat
title_full_unstemmed Atopic Dermatitis: The Fate of the Fat
title_short Atopic Dermatitis: The Fate of the Fat
title_sort atopic dermatitis: the fate of the fat
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880331/
https://www.ncbi.nlm.nih.gov/pubmed/35216234
http://dx.doi.org/10.3390/ijms23042121
work_keys_str_mv AT pavelpetra atopicdermatitisthefateofthefat
AT blunderstefan atopicdermatitisthefateofthefat
AT moosbruggermartinzverena atopicdermatitisthefateofthefat
AT eliaspeterm atopicdermatitisthefateofthefat
AT dubracsandrine atopicdermatitisthefateofthefat